<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Freeman JR</submitter><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>Intramural Research Program Cancer Research Training</funding><funding>NIH HHS</funding><pagination>434-444</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10919343</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>116(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Studies of sleep and prostate cancer are almost entirely based on self-report, with limited research using actigraphy. Our goal was to evaluate actigraphy-measured sleep and prostate cancer and to expand on findings from prior studies of self-reported sleep.&lt;h4>Methods&lt;/h4>We prospectively examined 34 260 men without a history of prostate cancer in the UK Biobank. Sleep characteristics were measured over 7 days using actigraphy. We calculated sleep duration, onset, midpoint, wake-up time, social jetlag (difference in weekend-weekday sleep midpoints), sleep efficiency (percentage of time spent asleep between onset and wake-up time), and wakefulness after sleep onset. Cox proportional hazards models were used to estimate covariate-adjusted hazards ratios (HRs) and 95% confidence intervals (CIs).&lt;h4>Results&lt;/h4>Over 7.6 years, 1152 men were diagnosed with prostate cancer. Sleep duration was not associated with prostate cancer risk. Sleep midpoint earlier than 4:00 am was not associated with prostate cancer risk, though sleep midpoint of 5:00 am or later was suggestively associated with lower prostate cancer risk but had limited precision (earlier than 4:00 am vs 4:00-4:59 am HR = 1.00, 95% CI = 0.87 to 1.16; 5:00 am or later vs 4:00-4:59 am HR = 0.79, 95% CI = 0.57 to 1.10). Social jetlag was not associated with greater prostate cancer risk (1 to &lt;2 hours vs &lt;1 hour HR = 1.06, 95% CI = 0.89 to 1.25; ≥2 hours vs &lt;1 hour HR = 0.90, 95% CI = 0.65 to 1.26). Compared with men who averaged less than 30 minutes of wakefulness after sleep onset per day, men with 60 minutes or more had a higher risk of prostate cancer (HR = 1.20, 95% CI = 1.00 to 1.43).&lt;h4>Conclusions&lt;/h4>Of the sleep characteristics studied, higher wakefulness after sleep onset-a measure of poor sleep quality-was associated with greater prostate cancer risk. Replication of our findings between wakefulness after sleep onset and prostate cancer are warranted.</pubmed_abstract><journal>Journal of the National Cancer Institute</journal><pubmed_title>Actigraphy-derived measures of sleep and risk of prostate cancer in the UK Biobank.</pubmed_title><pmcid>PMC10919343</pmcid><funding_grant_id>Y99 CA999999</funding_grant_id><funding_grant_id>Z99 CA999999</funding_grant_id><pubmed_authors>Saint-Maurice PF</pubmed_authors><pubmed_authors>Russ DE</pubmed_authors><pubmed_authors>Watts EL</pubmed_authors><pubmed_authors>Almeida JS</pubmed_authors><pubmed_authors>Shams-White MM</pubmed_authors><pubmed_authors>Hong HG</pubmed_authors><pubmed_authors>Caporaso NE</pubmed_authors><pubmed_authors>Wolff-Hughes DL</pubmed_authors><pubmed_authors>Moore SC</pubmed_authors><pubmed_authors>Loftfield E</pubmed_authors><pubmed_authors>Freeman JR</pubmed_authors><pubmed_authors>Matthews CE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Actigraphy-derived measures of sleep and risk of prostate cancer in the UK Biobank.</name><description>&lt;h4>Background&lt;/h4>Studies of sleep and prostate cancer are almost entirely based on self-report, with limited research using actigraphy. Our goal was to evaluate actigraphy-measured sleep and prostate cancer and to expand on findings from prior studies of self-reported sleep.&lt;h4>Methods&lt;/h4>We prospectively examined 34 260 men without a history of prostate cancer in the UK Biobank. Sleep characteristics were measured over 7 days using actigraphy. We calculated sleep duration, onset, midpoint, wake-up time, social jetlag (difference in weekend-weekday sleep midpoints), sleep efficiency (percentage of time spent asleep between onset and wake-up time), and wakefulness after sleep onset. Cox proportional hazards models were used to estimate covariate-adjusted hazards ratios (HRs) and 95% confidence intervals (CIs).&lt;h4>Results&lt;/h4>Over 7.6 years, 1152 men were diagnosed with prostate cancer. Sleep duration was not associated with prostate cancer risk. Sleep midpoint earlier than 4:00 am was not associated with prostate cancer risk, though sleep midpoint of 5:00 am or later was suggestively associated with lower prostate cancer risk but had limited precision (earlier than 4:00 am vs 4:00-4:59 am HR = 1.00, 95% CI = 0.87 to 1.16; 5:00 am or later vs 4:00-4:59 am HR = 0.79, 95% CI = 0.57 to 1.10). Social jetlag was not associated with greater prostate cancer risk (1 to &lt;2 hours vs &lt;1 hour HR = 1.06, 95% CI = 0.89 to 1.25; ≥2 hours vs &lt;1 hour HR = 0.90, 95% CI = 0.65 to 1.26). Compared with men who averaged less than 30 minutes of wakefulness after sleep onset per day, men with 60 minutes or more had a higher risk of prostate cancer (HR = 1.20, 95% CI = 1.00 to 1.43).&lt;h4>Conclusions&lt;/h4>Of the sleep characteristics studied, higher wakefulness after sleep onset-a measure of poor sleep quality-was associated with greater prostate cancer risk. Replication of our findings between wakefulness after sleep onset and prostate cancer are warranted.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-04T12:34:38.022Z</modification><creation>2025-04-04T12:34:38.022Z</creation></dates><accession>S-EPMC10919343</accession><cross_references><pubmed>38013591</pubmed><doi>10.1093/jnci/djad210</doi></cross_references></HashMap>